Development of a SARS Coronavirus Vaccine from Recombinant Spike Protein Plus Delta Inulin Adjuvant

Given periodic outbreaks of fatal human infections caused by coronaviruses, development of an optimal coronavirus vaccine platform capable of rapid production is an ongoing priority. This chapter describes the use of an insect cell expression system for rapid production of a recombinant vaccine agai...

Descripción completa

Detalles Bibliográficos
Autores principales: McPherson, Clifton, Chubet, Richard, Holtz, Kathy, Honda-Okubo, Yoshikazu, Barnard, Dale, Cox, Manon, Petrovsky, Nikolai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139448/
https://www.ncbi.nlm.nih.gov/pubmed/27076136
http://dx.doi.org/10.1007/978-1-4939-3387-7_14

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139448/
https://www.ncbi.nlm.nih.gov/pubmed/27076136
http://dx.doi.org/10.1007/978-1-4939-3387-7_14

Ejemplares similares